Redeye provides its initial view on Kontigo Care’s Q2 2025 results, which were broadly in line with expectations. Sales were slightly softer, while MRR came in ahead of forecast. License volumes increased during the quarter, with further upside expected from recently won municipal contracts that have not yet started to contribute. Cost levels remained well-managed, and the company’s cash position continues to support its product roadmap and international expansion. We expect only minor estimate revisions.
LÄS MER
